Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Intravenous fosfomycin for pulmonary exacerbation of cystic fibrosis: Real life experience of a large adult CF centre.

Spoletini G, Kennedy M, Flint L, Graham T, Etherington C, Shaw N, Whitaker P, Denton M, Clifton I, Peckham D.

Pulm Pharmacol Ther. 2018 Jun;50:82-87. doi: 10.1016/j.pupt.2018.04.007. Epub 2018 Apr 13.

PMID:
29660401
2.

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis.

Sawant A, Spoletini G, Whitaker P, Etherington C, Clifton I, Peckham D.

ERJ Open Res. 2018 Jan 10;4(1). pii: 00111-2017. doi: 10.1183/23120541.00111-2017. eCollection 2018 Jan.

3.

When Women with Cystic Fibrosis Become Mothers: Psychosocial Impact and Adjustments.

Cammidge SL, Duff AJ, Latchford GJ, Etherington C.

Pulm Med. 2016;2016:9458980. doi: 10.1155/2016/9458980. Epub 2016 Nov 23.

4.

Pathogenicity of individual rhinovirus species during exacerbations of cystic fibrosis.

Shah A, Connelly M, Whitaker P, McIntyre C, Etherington C, Denton M, Hale A, Harvala H, Simmonds P, Peckham DG.

Eur Respir J. 2015 Jun;45(6):1748-51. doi: 10.1183/09031936.00229114. No abstract available.

5.

Nursing's golden ages.

Etherington C.

Tenn Nurse. 2014 Winter;77(4):13. No abstract available.

PMID:
25549426
6.

The development and deployment of integrated electronic care records in a regional adult and paediatric cystic fibrosis unit.

Peckham D, Etherington C, White H, Mehta A, Shaw N, Morton A, Pollard K, Lee T, Brownlee K, Taylor J, Whitaker P, Conway S.

J Cyst Fibros. 2014 Dec;13(6):681-6. doi: 10.1016/j.jcf.2014.03.002. Epub 2014 Mar 23.

7.

The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation.

Etherington C, Naseer R, Conway SP, Whitaker P, Denton M, Peckham DG.

J Cyst Fibros. 2014 Jan;13(1):49-55. doi: 10.1016/j.jcf.2013.06.004. Epub 2013 Jul 23.

8.

How can simulated patients' experiences suggest ways to improve candidate performance in the MRCGP clinical assessments?

Russell D, Etherington C, Hawthorne K.

Educ Prim Care. 2012 Nov;23(6):391-8.

PMID:
23232130
9.

Bloodstream infections in cystic fibrosis: nine years of experience in both adults and children.

Cargill J, Etherington C, Peckham D, Conway S, Denton M.

J Cyst Fibros. 2012 Jul;11(4):337-9. doi: 10.1016/j.jcf.2012.02.004. Epub 2012 Mar 11.

10.

The use of nebulised aztreonam lysine (AZLI) in aztreonam hypersensitive patients.

Whitaker P, Etherington C, Williams K, Conway S, Peckham D.

J Cyst Fibros. 2012 Jul;11(4):353. doi: 10.1016/j.jcf.2012.01.007. Epub 2012 Feb 16. No abstract available.

11.

Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosis.

Haworth CS, Sharples L, Hughes V, Elkin SL, Hodson ME, Conway SP, Etherington C, Elborn JS, Rendall J, Wheaton E, Kadri E, Elliott J, Barker HC, Bearcroft PW, Hlaing T, Compston JE.

J Cyst Fibros. 2011 Dec;10(6):470-6. doi: 10.1016/j.jcf.2011.07.007. Epub 2011 Aug 16.

12.

Rapid desensitization for non-immediate reactions in patients with cystic fibrosis.

Whitaker P, Shaw N, Gooi J, Etherington C, Conway S, Peckham D.

J Cyst Fibros. 2011 Jul;10(4):282-5. doi: 10.1016/j.jcf.2011.02.002. Epub 2011 Mar 9.

13.

Sequential bronchoscopy in the management of lobar atelectasis secondary to allergic bronchopulmonary aspergillosis.

Whitaker P, Brownlee K, Lee T, Conway S, Etherington C, Peckham D.

J Bronchology Interv Pulmonol. 2011 Jan;18(1):57-60. doi: 10.1097/LBR.0b013e318206ea63.

PMID:
23169021
14.

Transition to independent practice: a national enquiry into the educational support for newly qualified GPs.

Griffin A, Abouharb T, Etherington C, Bandura I.

Educ Prim Care. 2010 Sep;21(5):299-307.

PMID:
20868545
15.

A/H1N1 flu pandemic. A/H1N1 and other viruses affecting cystic fibrosis.

Whitaker P, Etherington C, Denton M, Conway S, Peckham D.

BMJ. 2009 Sep 29;339:b3958. doi: 10.1136/bmj.b3958. No abstract available.

PMID:
19808817
16.

Acute Burkholderia cenocepacia pyomyositis in a patient with cystic fibrosis.

El-Laboudi AH, Etherington C, Whitaker P, Clifton IJ, Conway SP, Denton M, Peckham DG.

J Cyst Fibros. 2009 Jul;8(4):273-5. doi: 10.1016/j.jcf.2009.04.007. Epub 2009 May 17.

17.

Nutritional decline in cystic fibrosis related diabetes: the effect of intensive nutritional intervention.

White H, Pollard K, Etherington C, Clifton I, Morton AM, Owen D, Conway SP, Peckham DG.

J Cyst Fibros. 2009 May;8(3):179-85. doi: 10.1016/j.jcf.2008.12.002.

18.

Building global health through a center-without-walls: the Vanderbilt Institute for Global Health.

Vermund SH, Sahasrabuddhe VV, Khedkar S, Jia Y, Etherington C, Vergara A.

Acad Med. 2008 Feb;83(2):154-64. doi: 10.1097/ACM.0b013e318160b76c.

19.

Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.

Etherington C, Hall M, Conway S, Peckham D, Denton M.

J Antimicrob Chemother. 2008 Feb;61(2):425-7. Epub 2007 Dec 21.

PMID:
18156280
20.

Ten years of viral and non-bacterial serology in adults with cystic fibrosis.

Clifton IJ, Kastelik JA, Peckham DG, Hale A, Denton M, Etherington C, Conway SP.

Epidemiol Infect. 2008 Jan;136(1):128-34. Epub 2007 Mar 12.

21.

Nutritional status, perceived body image and eating behaviours in adults with cystic fibrosis.

Abbott J, Morton AM, Musson H, Conway SP, Etherington C, Gee L, Fitzjohn J, Webb AK.

Clin Nutr. 2007 Feb;26(1):91-9. Epub 2006 Sep 27.

PMID:
17007968
22.

Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.

Etherington C, Bosomworth M, Clifton I, Peckham DG, Conway SP.

J Cyst Fibros. 2007 Jan;6(1):67-73. Epub 2006 Jul 17.

23.

Associations between clinical variables and quality of life in adults with cystic fibrosis.

Gee L, Abbott J, Hart A, Conway SP, Etherington C, Webb AK.

J Cyst Fibros. 2005 Mar;4(1):59-66.

24.

Burkholderia cepacia complex infection in adult patients with cystic fibrosis--is early eradication possible?

Etherington C, Peckham DG, Conway SP, Denton M.

J Cyst Fibros. 2003 Dec;2(4):220-1. No abstract available.

25.

Quality of life in cystic fibrosis: the impact of gender, general health perceptions and disease severity.

Gee L, Abbott J, Conway SP, Etherington C, Webb AK.

J Cyst Fibros. 2003 Dec;2(4):206-13.

26.

A pilot study of zafirlukast as an anti-inflammatory agent in the treatment of adults with cystic fibrosis.

Conway SP, Etherington C, Peckham DG, Whitehead A.

J Cyst Fibros. 2003 Mar;2(1):25-8.

27.

Predictors of desaturation during formal hypoxic challenge in adult patients with cystic fibrosis.

Peckham D, Watson A, Pollard K, Etherington C, Conway SP.

J Cyst Fibros. 2002 Dec;1(4):281-6.

28.

Validation of the SF-36 for the assessment of quality of life in adolescents and adults with cystic fibrosis.

Gee L, Abbott J, Conway SP, Etherington C, Webb AK.

J Cyst Fibros. 2002 Sep;1(3):137-45.

29.

Pharmacokinetics and safety of itraconazole in patients with cystic fibrosis.

Conway SP, Etherington C, Peckham DG, Brownlee KG, Whitehead A, Cunliffe H.

J Antimicrob Chemother. 2004 May;53(5):841-7. Epub 2004 Mar 24.

PMID:
15044430
30.

Seeing the best and worst of humanity. Interview by Carl Bloice.

Etherington C.

Revolution. 2003 Dec;4(6):8-14. No abstract available.

PMID:
14746215
31.

Serum and sputum concentrations following the oral administration of linezolid in adult patients with cystic fibrosis.

Saralaya D, Peckham DG, Hulme B, Tobin CM, Denton M, Conway S, Etherington C.

J Antimicrob Chemother. 2004 Feb;53(2):325-8. Epub 2004 Jan 16.

PMID:
14729733
32.

Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis.

Li J, Coulthard K, Milne R, Nation RL, Conway S, Peckham D, Etherington C, Turnidge J.

J Antimicrob Chemother. 2003 Dec;52(6):987-92. Epub 2003 Oct 29.

PMID:
14585859
33.

Alcaligenes infection in cystic fibrosis.

Tan K, Conway SP, Brownlee KG, Etherington C, Peckham DG.

Pediatr Pulmonol. 2002 Aug;34(2):101-4.

PMID:
12112775
34.

The role of IDA scintigraphy in the follow-up of liver disease in patients with cystic fibrosis.

Foster JA, Ramsden WH, Conway SP, Taylor JM, Etherington C.

Nucl Med Commun. 2002 Jul;23(7):673-81.

PMID:
12089490
35.

Once-daily tobramycin in the treatment of adult patients with cystic fibrosis.

Whitehead A, Conway SP, Etherington C, Caldwell NA, Setchfield N, Bogle S.

Eur Respir J. 2002 Feb;19(2):303-9.

36.

Cross cultural differences in health related quality of life in adolescents with cystic fibrosis.

Abbott J, Baumann U, Conway S, Etherington C, Gee L, Von Der Schulenburg JM, Webb K.

Disabil Rehabil. 2001 Dec 15;23(18):837-44.

PMID:
11763280
37.

Perceived body image and eating behavior in young adults with cystic fibrosis and their healthy peers.

Abbott J, Conway S, Etherington C, Fitzjohn J, Gee L, Morton A, Musson H, Webb AK.

J Behav Med. 2000 Dec;23(6):501-17.

PMID:
11199084
38.

Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis.

Conway SP, Etherington C, Munday J, Goldman MH, Strong JJ, Wootton M.

Ann Pharmacother. 2000 Nov;34(11):1238-42.

PMID:
11098334
39.
40.

Ocular signs and symptoms and vitamin A status in patients with cystic fibrosis treated with daily vitamin A supplements.

Ansari EA, Sahni K, Etherington C, Morton A, Conway SP, Moya E, Littlewood JM.

Br J Ophthalmol. 1999 Jun;83(6):688-91.

41.

Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis.

Conway SP, Pond MN, Watson A, Etherington C, Robey HL, Goldman MH.

Thorax. 1997 Nov;52(11):987-93.

42.

Working in international war zones: a personal account.

Etherington C.

Tenn Nurse. 1995 Oct;58(5):14-6. No abstract available.

PMID:
7492564

Supplemental Content

Loading ...
Support Center